Table 5.
Effect of GSE and GSE/quercetin on clotting and fibrinolytic factors. N = 35, mean SD.
| Baseline | Period 2 | Period 3 | Period 4 | GSE | GSE/quercetin | Control | |
|---|---|---|---|---|---|---|---|
| VWF (%) | — | 115.58 ± 39.12 | 101.66 ± 35.82 | 102.37 ± 35.55 | 109.11 ± 36.06 | 104.50 ± 39.58 | 106.00 ± 36.40 |
| PAI-1 ng/mL | — | 50.47 ± 33.51 | 45.22 ± 21.41 | 49.27 ± 31.72 | 50.47 ± 35.77 | 48.58 ± 29.24 | 45.90 ± 21.41 |
| PAI-1 activity | 16.45 ± 9.72 | 16.27 ± 9.08 | 16.28 ± 8.05 | 16.28 ± 10.37 | 15.39 ± 9.30 | 16.78 ± 10.05 | 16.76 ± 8.13 |
| tPA (ng/mL) | — | 7.235 ± 3.396 | 6.636 ± 2.350 | 6.857 ± 2.378 | 6.929 ± 2.686 | 6.908 ± 2.835 | 6.891 ± 2.766 |
| tPA activity | 1.432 ± 1.204 | 1.295 ± 0.865 | 1.140 ± 0.715 | 1.269 ± 1.011 | 1.261 ± 0.822 | 1.146 ± 0.764 | 1.297 ± 1.011 |
| tPA/PAI-1 activity | 20.37 ± 21.63 | 20.91 ± 21.15 | 24.46 ± 24.06 | 27.11 ± 32.45 | 24.12 ± 27.75 | 26.05 ± 29.90 | 23.04 ± 21.3 |
| tPA/PAI-1 mass | — | 0.205 ± 0.348 | 0.188 ± 0.483 | 0.194 ± 0.648 | 0.187 ± 0.119 | 0.206 ± 0.179 | 0.195 ± 0.138 |